SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 02/16/2026 at 07:05, 1 month 9 days ago

Beyfortus proves its effectiveness beyond the first season of VRS

Sanofi VRS Beyfortus Infants Immunization
BRIEF

published on 02/16/2026 at 07:05, 1 month 9 days ago

Beyfortus Shows Extended Benefits for Infants Against RSV

Infant Health Beyfortus Hospitalization Reduction RSV Immunization NIRSE-GAL Study
PRESS RELEASE

published on 02/16/2026 at 07:00, 1 month 9 days ago

Press Release: Beyfortus study published in The Lancet Infectious Diseases shows benefit for infants beyond first RSV season
Universal RSV immunization with Beyfortus reduces hospitalizations in infants across two seasons, as per study in The Lancet Infectious Diseases and RSVVW '26 conference findings

RSV Beyfortus Infants Immunization Hospitalizations
BRIEF

published on 02/10/2026 at 15:05, 1 month 15 days ago

Sanofi Finalizes Acquisition of Dynavax

Acquisition Biopharma Sanofi Vaccines Dynavax
PRESS RELEASE

published on 02/10/2026 at 15:00, 1 month 15 days ago

Press Release: Sanofi completes the acquisition of Dynavax
Sanofi completes acquisition of Dynavax, bolstering presence in adult immunization with HEPLISAV-B vaccine and Z-1018 shingles vaccine candidate, enhancing global reach and development capabilities

Acquisition Sanofi Vaccine Immunization Dynavax
BRIEF

published on 02/03/2026 at 07:05, 1 month 22 days ago

Sanofi Signs €1 Billion Share Buyback Mandate

Share Buyback Investment Financial Strategy Biopharma Sanofi
PRESS RELEASE

published on 02/03/2026 at 07:00, 1 month 22 days ago

Press Release: Sanofi announces the signing of a share buyback mandate for up to €1 billion
Sanofi signs share buyback mandate for up to €1 billion, intending to repurchase own shares between February 3, 2026, and December 31, 2026

Share Buyback Investment Sanofi Mandate €1 Billion
BRIEF

published on 01/30/2026 at 13:05, 1 month 26 days ago

Sanofi's Rezurock Recommended for EU Approval by CHMP

Sanofi EU Market CHMP Approval Rezurock Chronic GVHD
BRIEF

published on 01/30/2026 at 13:05, 1 month 26 days ago

The CHMP recommends approval of Sanofi's Rezurock for the treatment of chronic GVHD

Treatment Sanofi Rezurock CHAMP GVHD
PRESS RELEASE

published on 01/30/2026 at 13:00, 1 month 26 days ago

Press Release: Sanofi’s Rezurock recommended for EU approval by the CHMP to treat chronic graft-vs-host disease
Sanofi's Rezurock recommended for EU approval by the CHMP for chronic graft-vs-host disease treatment, based on clinical studies. New treatment option for patients

Sanofi EU Approval CHMP Recommendation Rezurock Chronic GVHD

Published on 03/25/2026 at 19:15, 1 hour 44 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 7 hours 29 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 7 hours 29 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 7 hours 29 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 7 hours 34 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets

View all ACCESSWIRE

Published on 03/25/2026 at 20:00, 58 minutes ago

Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 1 hour 17 minutes ago

EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 1 hour 28 minutes ago

AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 1 hour 32 minutes ago

EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 2 hours 18 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS

View all EQS

Published on 03/25/2026 at 18:53, 2 hours 5 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 2 hours 27 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 3 hours 14 minutes ago

Combined General Meeting on May 05, 2026: publication of the notice of Meeting
Published on 03/25/2026 at 17:45, 3 hours 14 minutes ago

GUILLEMOT CORPORATION: 2025 ANNUAL RESULTS
Published on 03/25/2026 at 17:42, 3 hours 17 minutes ago

2025/2026 Second quarter Sales

View all LES ECHOS COMFI WIRE

News